Cytoxan

Utilized to target malignant neoplasms to alleviate disease progression and cell proliferation.

Strengths: 50mg

Medicine details

Alternative names

Endoxan

Therapeutic class

Alkylating Agent

Pharmacological class

Mustard Nitrogen Analogue

Known off-label uses

severe rheumatoid arthritis; systemic lupus erythematosus

Contraindications

severe bone marrow suppression; hypersensitivity; active infection

Minor side effects

nausea; alopecia; fatigue

Moderate side effects

cystitis; immunosuppression; infertility

Dosage forms

Tablet; Powder for solution for injection

Administration route

Oral use

Prescription status

POM

Manufacturer

Baxter

Onset Time

1–2 weeks

Duration

varies by regimen

Storage instructions

Store at room temperature, keep dry.

Drug interactions

Doxorubicin; Allopurinol

Age restrictions

paediatric use requires expert supervision.

Precautions and warnings

maintain adequate hydration; regular blood count monitoring; risk of secondary malignancies

Serious side effects

haemorrhagic cystitis — requires immediate medical attention; bone marrow failure — requires immediate medical attention

Patient summary

Utilized to target malignant neoplasms to alleviate disease progression and cell proliferation.

Mechanism of action

This chemotherapy agent works by cross-linking DNA, which prevents cancer cells from dividing and growing. It is often used as part of combination therapy to manage various types of blood and solid cancers.

Pregnancy and breastfeeding

Pregnancy: Highly teratogenic; must be avoided. Breastfeeding: Absolutely contraindicated; discontinue breastfeeding.

Cytoxan

Utilized to target malignant neoplasms to alleviate disease progression and cell proliferation.

Editorial Notes

  • Active ingredient(s): Cyclophosphamide
  • Listed indication(s): Malignant Lymphoma, Multiple Myeloma, Leukaemia

Available option

  • 30 tablets - 50 mg264-50-mg-2641